Cannabis and Hemp Industry Investment News
The medical life science company received a government grant of $75,000 for the clinical depression trial, which was conducted at the Queensland Unive...
The Vancouver-based company said it will focus efforts on the establishment and expansion of its Portuguese and European operations The loan agreemen...
Lexaria Pharmaceutical will look at how DehydraTECH could improve delivery and effectiveness of antiviral drugs to treat coronavirus Researchers are l...
The program will study the benefits of its DehydraTECH technology for boosting the delivery and effectiveness of fat-soluble antiretroviral drugs Lexa...
What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE:LXX-OTCQX: LXRP) CEO Chris Bunka joined Steve Darling from Proactive ...
Medlab has developed the virtual clinic so that anyone can have access to a free, no-obligation, 10-minute confidential consultation via any computer ...
The last tranche raised C$645,000 by offering nearly 1.3 million units at a price of $0.50 per unit Canntab has filed 13 patents in Canada and the US ...
The strong results allow Medlab to focus on phase three designs specifically in the patient group with metastatic bone pain where breast or prostate a...
The incoming chairman previously served as the CEO of Katz Group Canada, which owns and operated a network of leading pharmacies across Canada The app...
The NanaBis™ study seeks to recruit 2,000 Australian patients via medical or hospital settings to provide intervention data over a 12-month period. Me...
The super-concentrated DehydraTECH-enabled liquid nanoemulsion was shipped to the client's production facility for incorporation into its cold-brewed ...
What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics (CSE: PILL-OTCQB: CTABF) CFO Richard Goldstein joined Steve Darling from...
The Vancouver-based company is building the operation to distribute medical cannabis ingredients for cannabis-based compounds and active pharmaceutica...
The company is getting ready to move into full-scale manufacturing of its cannabinoid pills The company plans to roll out new brands and products for ...
What are you searching for? viewCanntab Therapeutics Ltd Canntab Therapeutics Limited (CSE:PILL-OTCQB: CTABF) Co-Founder and CFO Richard Goldstein joi...
It marks the final step to obtain a standard processing licence and sale for medical purposes licence Canntab’s facility in Markham, Ontario, is equip...
() CEO & managing director Dr. Sean Hall tells Proactive Investors, "probably one of the biggest things in medicine to date" is research into the ...
NanoCelle™ is a mouth spray delivery system targeting cannabis-based medicines. Research is being conducted by University of Sydney’s Nano Institute (...
Three studies are the focus as the company targets chronic illnesses, including cancer, using a pipeline that includes cannabis products and probiotic...
The Sydney-based investor has demonstrated confidence in the company’s medical research strategy. Farjoy now holds almost 24 million shares, or 11.53%...
